Search

everythinglearnresearchcommunity

for

Search:↓

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

Certain cancer drugs interact with skin bacteria to cause acne-like rashes.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Tofacitinib is effective for treating alopecia totalis and universalis, with some patients experiencing significant hair regrowth.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Cetuximab often causes skin rashes, and managing these is important for cancer treatment.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

Baricitinib effectively reduces hair loss in alopecia areata and is well-tolerated.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

The study evaluated how alopecia areata severity relates to its psychosocial effects on patients.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Mexican patients had a lower incidence of skin reactions to drugs and no significant link between these reactions and the TNF2 gene variant.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Mood stabilizers for bipolar disorder can cause skin issues, but severe reactions are rare.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

EGFR inhibitors can cause skin issues, and managing these is important for treatment success.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Any medication can cause skin reactions, some due to allergies and others due to dosage or genetic factors.

Sorafenib can cause facial acne-like eruptions, which improve after reducing the dose or stopping the drug.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Early treatment of acne is crucial to prevent scarring and psychological effects.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

A patient's skin eruption was caused by the cancer drug cyclophosphamide and improved after stopping the drug.